Canada markets open in 6 hours 38 minutes

Xtant Medical Holdings, Inc. (XTNT)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.5298+0.0134 (+2.59%)
At close: 02:27PM EDT
0.5299 +0.00 (+0.02%)
After hours: 07:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.5164
Open0.5100
Bid0.0000 x 1000
Ask0.0000 x 1200
Day's Range0.4929 - 0.5300
52 Week Range0.4500 - 1.3600
Volume19,081
Avg. Volume30,982
Market Cap46.259M
Beta (5Y Monthly)1.03
PE Ratio (TTM)N/A
EPS (TTM)-0.0890
Earnings DateNov 10, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Xtant Medical Announces Second Quarter 2022 Financial Results

    BELGRADE, Mont., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2022. “We are pleased to have achieved our highest revenue quarter since the start of the pandemic. Our second quarter revenue increased 2% over the same prior year period, including 8% year-over-year growth

  • GlobeNewswire

    Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022

    BELGRADE, Mont., July 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June 30, 2022, before the open of the financial markets on Thursday, August 4, 2022. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference ca

  • GlobeNewswire

    Xtant Medical Announces First Quarter 2022 Financial Results

    BELGRADE, Mont., May 05, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2022. “By building momentum in our business, underscored by first quarter revenue growth and the progress of our key strategic growth pillars, we are pleased with the promising start to 2022,” said Sean Brown